In brief
Warhound has raised $200 million and is valued at $1.2 billion, with In-Q-Tel, Sequoia and 8VC among its named investors.
More than 80% of working dogs used by the US military come from Europe, and less than half of the animals acquired are fit for service, according to the company.
The first stage targets hip dysplasia, vision problems, certain cancers and muscle atrophy before cloning, with first puppies expected in early 2027.
Anduril will develop vests, body armor and goggles, plus the software and hardware for them, while Lamm says the current plan is armor rather than implants.
- 22 OctWarhound emerges from stealth with $200 million in funding
- Early 2027First genetically engineered puppies expected to be born
Funding and backers
Warhound emerged from stealth on Thursday, 22 October 2026, with $200 million in funding that values the company at $1.2 billion. Named investors include In-Q-Tel, Sequoia and 8VC, and some reporting also lists ARK Invest. The startup was conceived by Ben Lamm, co-founder of Colossal Biosciences, and Palmer Luckey, the Oculus VR founder who co-founded Anduril Industries. Lamm sits on Warhound's board and Colossal holds an ownership stake, while Luckey and Anduril hold no equity in the company. The chief executive is David Spirk, a former Department of Defense chief data officer who most recently worked at Palantir. The company is based in Texas.
- Funding raised
- 200 US$ million
- Valuation
- 1200 US$ million
Data from the article text
Engineering the dogs
The company argues that the United States depends too heavily on European breeders for its military working dogs. It says more than 80% of working dogs used by the US military come from Europe, and fewer than half of the animals acquired are fit for service. Selection and training can extend for roughly three years, so many dogs never finish because of physical problems, illness or traits that make them unsuited to the work. Warhound plans to combine cloning with gene editing to change that equation. The company has collected cell samples from top-performing military, police and first responder dogs in the United States, mostly Belgian Malinois, some labradors and some shepherds, and placed them in a biobank. Colossal scientists will first target hip dysplasia, vision problems, a predisposition to certain cancers and muscle atrophy. Later work could make the dogs faster, more agile or better at smelling, and ViaGen, a cloning company linked to Colossal, is expected to produce the first animals.
Anduril's role and the cyborg question
Anduril would design protective vests, body armor and goggles, plus the software and hardware that run them, so the dogs and their handlers can share situational awareness. Some coverage has framed the dogs as cyborgs, but the plan described so far centers on armor and gear rather than implants. Lamm has offered the example of bulletproof vests with data sensors that report back to handlers. Asked whether the dogs would carry lasers, Lamm declined to speak for Anduril, but he described the mission this way.
“Dog safety and performance, and then helping continue helping to improve the human handler and dog bond, and working as a team -- that is what the mission is.”
Missions and timeline
Warhound says the dogs would be trained for bomb detection, searches and other specialized operations, along with work for emergency responders. The company wants to rebuild the domestic supply of elite working dogs, which it sees as the way to reduce dependence on European breeders. Lamm and Luckey have been working on the project for over a year, and the company says the first batch of dogs is already being gene-edited. No product exists yet, and the first puppies are expected to be born in early 2027.